CPR The Remedy, which will handle a programme promoting Takeda’s four major brands, replaces Shire Health Group firm 4D Communications on the account – which will be worth more than £1m per year to the agency.
Oxford-based 4D, which has held the Takeda contract for four years, pitched for the account, along with med ed giant Medical Action Communications.
Both CPR Worldwide and The Remedy have already worked for Takeda, promoting hypertension and chronic heart failure product candesartan. The fresh contract includes candesartan, as well as lansoprazole for gastrointestinal disease, leuprorelin for the treatment of prostate cancer and certain gynaecological conditions and pioglitazone for Type II diabetes.
The Remedy managing director Kate Hawker reports to Takeda European marketing director David Roberts on the remit, which will involve work at events such as the annual congress of the European Society for Cardiology.
The appointment follows an agency search process that is understood to have kicked off seven months ago.
4D will cease to work on the account at the end of this year.